Rohini Joshi
Neurology · Modesto, CANPI 1538190806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.4% of the total across 419 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,619 and has fallen 96.5% since, to $125 in 2025.
Across 419 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$1K
- Livanova USA, Inc.$1K
- Novartis$663
- Teva Pharmaceuticals USA, Inc.$584
- Eisai Inc.$350
- plus $3K from 34 others
What the payments were for
- Speaking & faculty fees$75010%
- Food & beverage$7,04290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $1,317 |
| Supernus Pharmaceuticals, Inc. | 56 | $1,065 |
| Livanova USA, Inc. | 120 | $1,042 |
| Novartis | 22 | $663 |
| Teva Pharmaceuticals USA, Inc. | 42 | $584 |
| Eisai Inc. | 9 | $350 |
| Lilly USA, LLC | 13 | $215 |
| UCB, Inc. | 11 | $215 |
| AstraZeneca | 12 | $188 |
| Amgen | 6 | $166 |
| Genentech USA, Inc. | 2 | $164 |
| Sunovion Pharmaceuticals Inc. | 11 | $133 |
| SK Life Science, Inc. | 7 | $133 |
| EMD Serono, Inc. | 8 | $127 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Kyowa Kirin, Inc. | 6 | $124 |
| MDD US Operations, LLC | 3 | $112 |
| Sanofi | 6 | $111 |
| Avanir Pharmaceuticals, Inc. | 5 | $103 |
| Biohaven Pharmaceuticals, Inc. | 6 | $102 |
| E.r. Squibb & Sons, L.L.C. | 5 | $94 |
| GE HealthCare | 3 | $77 |
| Acadia Pharmaceuticals Inc | 5 | $74 |
| Biogen | 3 | $68 |
| Assertio Therapeutics, Inc. | 4 | $61 |
| Upsher-smith Laboratories LLC | 2 | $46 |
| Amneal Pharmaceuticals LLC | 3 | $43 |
| Mallinckrodt Enterprises LLC | 2 | $38 |
| Neurelis, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| Boston Scientific | 1 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Merz North America, Inc. | 1 | $20 |
| Impel Pharmaceuticals Inc. | 1 | $17 |
| 180 Medical, Inc. | 1 | $15 |
| Bayer | 1 | $12 |
| Pfizer | 1 | $11 |
| OWP Pharmaceuticals, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,792 in reported general payments places this provider in the 70th percentile of 1,996 neurology providers in California.
Other neurology in Modesto
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.